CAY10614

Overview

CAY10614 is a potent TLR4 antagonist. CAY10614 inhibits the lipid A-induced activation of TLR4 , with an IC 50 of 1.675 μM. CAY10614 can improve survival of mice in lethal endotoxin shock model.

Application

Products | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Pain | Products > Disease Areas > Obesity | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Toll-like Receptor (TLR)

Product Information

• Catalog No.: HY-135042
• CAS No.: 1202208-36-3
• Molecular Formula: C42H78INO2
• Molecular Weight: 755.98
• Purity: 98.87%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: 0.83 mg/mL (1.10 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source